Clin2
NCT07461337Worth exploringNot yet recruiting

Bacteriophage therapy for stubborn joint infections

Prosthetic Joint Infections of HipBacteriophage Therapy

Part of Bones, joints & muscles, Infections clinical trials.

This trial tests a treatment using viruses that attack bacteria to fight a chronic infection in a joint replacement. It might help people whose joint infection has not cleared up with standard antibiotics or surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
1 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have an active, long-term infection in your joint replacement
  • The bacteria causing your infection can be killed by the study treatment
  • You have already tried several antibiotic treatments or surgeries without success
  • You do not have severe kidney disease or liver damage (cirrhosis)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07619924Enrolling by invitation· Early Phase 1
Phage Cocktail for Hard-to-Treat Skin Infections

This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.

Xi'an, Shaanxi
NCT07429162Not yet recruiting· Phase 1
Bacteriophage treatment for drug-resistant lung infection

This trial tests a treatment using bacteriophages (viruses that attack specific bacteria) to fight a tough lung infection called Mycobacterium abscessus that doesn't respond to usual antibiotics. If you have this infection, this treatment might offer a new way to clear it.

NCT06771050Recruiting· Phase 4
Antibiotics and surgery for hip and knee joint infections

This trial tests different antibiotic types and durations, plus surgical approaches, for people with a current joint infection in a hip or knee. It aims to find the best way to treat the infection and prevent it from coming back.

Garran, Australian Capital Territory
NCT06798168AVAILABLE
Phage therapy for drug-resistant joint infections

This trial studies a treatment using viruses that attack bacteria (called phages) to fight a stubborn joint infection that hasn't improved with other treatments. It may help people with chronic infections that resist antibiotics.

Ottawa
NCT06942624Not yet recruiting· Phase 1/Phase 2
Phage therapy for a long-term joint replacement infection

This trial tests a special treatment using viruses (called phages) that target and kill the bacteria causing a long-term joint replacement infection. It's designed for people who have tried many other treatments without success.

Winnipeg, Manitoba
NCT06605651Not yet recruiting· Phase 2
Phage therapy for knee or hip joint infections caused by staph bacteria

This trial tests a new treatment using viruses that attack bacteria (called phages) to fight infections in knee or hip replacements caused by Staphylococcus aureus. It may help people who still have the infection after a surgery to clean the joint, called DAIR.

Hear when a new Prosthetic Joint Infections of Hip trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.